Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Everest Medicines Limited
  6. News
  7. Sector news
    1952   KYG3224E1061

EVEREST MEDICINES LIMITED

(1952)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Biopharmaceuticals
10/15BIOGEN : Stifel Adjusts Biogen's Price Target to $344 from $430, Keeps Buy Rating
MT
10/15BIOGEN : Cantor Fitzgerald Adjusts Price Target on Biogen to $327 From $427, Maintains Neu..
MT
10/15South Korean Stocks Close Higher on Chip Shares' Gains; Samsung, SK Hynix Move Markets
MT
10/15Analysis-Deals, data buzz could help biotech shares exit Wall St's 'no man's land'
RE
10/15CSL : Reaffirms Commitment to Manufacture 50 Million Doses of AstraZeneca Vaccine
MT
10/15Deals, data buzz could help biotech shares exit Wall St's 'no man's land'
RE
10/13Australia's CSL reaffirms commitment to making AstraZeneca COVID vaccine
RE
10/13Australia's CSL reiterates manufacturing commitment with AstraZeneca COVID-19 vaccine
RE
10/13BIOGEN : Preliminary Analysis Suggests Certain Multiple Sclerosis Therapies May Reduce COV..
MT
10/13Biogen Inc. Announces New Data from its Industry-Leading Portfolio of Multiple Sclerosi..
CI
10/13BIOGEN : People Treated With MS Therapies Achieve Antibody Response to Covid-19 Vaccinatio..
DJ
10/12BIOGEN : Morgan Stanley Adjusts Biogen PT to $447 from $455, Keeps Overweight Rating
MT
10/11CSL Limited Provides Earnings Guidance for Fiscal Year 2022
CI
10/10SAMSUNG BIOLOGICS : Enzolytics Sign Deal for Anti-HIV, Anti-COVID-19 Monoclonal Antibody T..
MT
10/08BIOGEN : Jefferies Adjusts Biogen PT to $400 from $500, Keeps Buy Rating
MT
10/08BIOGEN : Barclays Adjusts Biogen's Price Target to $290 from $395, Keeps Equalweight Ratin..
MT
10/08Hong Kong shares close 0.6% higher as tech and financial stocks gain
RE
10/08LI NING : China stocks rise on strong services data, easing Sino-U.S. tensions
RE
10/07Enzolytics Inc. and Samsung Biologics Co., Ltd. Announce Development and Manufacturing ..
CI
10/06BIOGEN : RBC Trims Price Target on Biogen to $325 From $326, Maintains Sector Perform Rati..
MT
10/06ANALYST RECOMMENDATIONS : American Airlines, Biogen, Morgan Stanley, Rolls-Royce, United S..
10/06Alexion Pharmaceuticals, Inc. completed the acquisition of remaining majority stake in ..
CI
10/05BIOGEN : Wedbush Adjusts Price Target for Biogen to $297 From $314, Maintains Neutral Rati..
MT
10/04Seqirus, Part of CSL Limited Awarded U.S. Government Contract to Develop Two Pandemic I..
CI
10/04Sage Therapeutics and Biogen Announces Consistent Clinically Meaningful Data for Zurano..
CI
10/01Thermo Fisher Scientific Opens Manufacturing Site in Switzerland
DJ
09/30SIHUAN PHARMACEUTICAL : Pharma, WuXi Bio Units to Collaborate on Breast Cancer Drug Candid..
MT
09/29AstraZeneca's Alexion to Advance and Accelerate Ongoing Phase III Clinical Development ..
CI
09/29BIOGEN : RBC Cuts Price Target on Biogen to $326 From $341, Noting 'Slow Aduhelm Uptake,' ..
MT
09/29Alexion Pharmaceuticals, Inc. agreed to acquire remaining majority stake in Caelum Bios..
CI
09/28BIOGEN : Partner Eisai Launches Rolling Submission of Biologics License Application With F..
MT
09/23BIOGEN : Needham Starts Biogen at Buy With $400 Price Target
MT
09/22Samsung Biologics showcases its newest CDO process platform, S-CellerateÖ, at BPI 2021,..
CI
09/20BIOGEN : Samsung Bioepis' Byooviz Approved by FDA
MT
09/20FDA Approves Samsung Bioepis and Biogen’s BYOOVIZ, LUCENTIS Biosimilar (ranibizumab-nun..
CI
09/20Biogen, Samsung Bioepis Get FDA OK for Lucentis Biosimilar
DJ
09/17Preview -- Barron's
DJ
09/17BIOGEN : Vumerity Receives Marketing Recommendation From European Medicines Agency
MT
09/17Biogen Inc. Receives Approval from European Medicines Agency for VUMERITY in the Europe..
CI
09/17MODERNA : U.S. FDA advisers may vote on COVID-19 boosters for older adults after rejecting..
RE
09/17Biogen Gets CHMP Backing for Vumerity in Multiple Sclerosis
DJ
09/17South Korea Stocks Rise on Upbeat August US Retail Sales; Samsung Electronics Adds 1%
MT
09/17Shanghai stocks fall as coal shares drag; Hong Kong rebounds
RE
09/16BIOGEN : UBS Adjusts Biogen PT to $442 From $475, Maintains Buy Rating
MT
09/16BIOGEN : Study of Vixotrigine in Small Fiber Neuropathy Meets One Endpoint, Misses Another..
MT
09/16Biobiogen Inc. Announces Positive Topline Results from Phase 2 Convey Study in Small Fi..
CI
09/16Biogen Drug Candidate for Small Fiber Neuropathy Meets Primary Endpoint for 200 Milligr..
DJ
09/15Correction to Biogen Plans Phase 3b Trial Article
DJ
09/15BIOGEN : to Conduct Phase 3b Study of Higher Dose of Nusinersen in Patients Previously Tre..
MT
09/15Biogen Inc Announces Plans to Initiate Global Phase 3B Clinical Study, ASCEND
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on EVEREST MEDICINES LIMITED
Upcoming sector events